Bristol-Myers Q4 Non-GAAP Earnings Fall, Revenue Rises; 2026 Guidance Set -- Shares Up Pre-Bell
MT Newswires Live
Feb 05
Bristol-Myers Squibb (BMY) reported Q4 non-GAAP earnings Thursday of $1.26 per diluted share, down from $1.67 a year earlier.
Analysts surveyed by FactSet expected $1.23.
Revenue for the quarter ended Dec. 31 was $12.50 billion, compared with $12.34 billion a year earlier.
Analysts surveyed by FactSet expected $12.28 billion.
For 2026, the company expects adjusted EPS of $6.05 to $6.35 on revenue of $46 billion to $47.50 billion. Analysts are looking for $6.02 and $44.18 billion, respectively.
Bristol-Myers shares were up 4.4% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.